Biomarkers Market Size, Share, Trends, Growth 2032

Biomarkers Industry Prospective:

The global biomarkers market size was worth around USD 67.41 billion in 2023 and is predicted to grow to around USD 237.15 billion by 2032 with a compound annual growth rate (CAGR) of roughly 15.00% between 2024 and 2032.

Request Free Sample

The report covers a forecast and an analysis of the biomarkers market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes the drivers and restraints of the biomarkers market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the biomarkers market on a global level.

Biomarkers Market: Growth Drivers

A biomarker is a substance that can be introduced among organisms to inspect organ functions or other aspects of their health. A biomarker is objectively evaluated and measured as an indication of typical pathogenic processes, biological processes, or pharmacologic responses to therapeutic interventions. Biomarkers are genetic molecules produced either by human tissues or tumor cells in response to cancer. These molecules are then evaluated and measured as a mark of cancerous processes inside the body. Biomarkers are widely used in the management and detection of diseases in the patient population.

The growing prevalence of cancer and cardiovascular diseases, increasing healthcare expenditure for the diagnosis and treatment of chronic diseases are projected to fuel the global biomarkers market. Furthermore, the encouraging initiative by government and high adoption of technically advanced products will also boost the biomarker market in the future.

Request Free Sample

In order to give the users a comprehensive view of the biomarkers market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launch, agreements, partnerships, collaborations & joint ventures, research & development, technology, and regional expansion of major participants involved in the market on a global and regional basis.

Biomarkers Market : Report Scope

Biomarkers Market: Segmentation

The study provides a decisive view of the biomarkers market by segmenting it based on biomarker type, application, disease, and region.

Based on biomarker type, the biomarkers market is categorized into safety, validation, and efficacy biomarkers. Based on application, the biomarkers market includes personalized medicine, diagnostic, drug discovery and development, and others. By disease, the biomarkers market comprises immunological diseases, cancer, neurological diseases, cardiovascular diseases, and others. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Biomarkers Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America dominated the biomarkers market globally in 2018 and is likely to remain dominant over the forecast time period as well. This regional dominance can be attributed to the regional presence of major pharmaceutical and biotechnology companies, increasing adoption of the latest technologies, and established healthcare infrastructure. The Asia Pacific region is expected to record high growth in the biomarkers market globally in the years ahead. The growing support of the regional governments for drug discovery and development programs and large patient pool are the major factors boosting the biomarkers market development in the Asia Pacific.

Biomarkers Market: Competitive Analysis

The global biomarkers market is led by players like:

• Agilent Technologies
• F. Hoffmann-La Roche
• Epigenomics
• Abbott
• Thermo Fisher Scientific
• Johnson & Johnson
• Siemens Healthcare
• Bio-Rad Laboratories
• Qiagen

This report segments the global biomarkers market into:

Global Biomarkers Market: Biomarker Type Analysis

• Safety Biomarkers
• Efficacy Biomarkers
• Validation Biomarkers

Global Biomarkers Market: Application Analysis

• Diagnostic
• Drug Discovery and Development
• Personalized Medicine
• Others

Global Biomarkers Market: Disease Analysis

• Cancer
• Cardiovascular Diseases
• Neurological Diseases
• Immunological Diseases
• Others

Global Biomarkers Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa